Literature DB >> 3137019

Valproate in the treatment of absence epilepsy in children: a study of dose-response relationships.

G Braathen1, K Theorell, A Persson, A Rane.   

Abstract

Seven children with absence epilepsy were treated with valproate (VPA). All but one child became free of absence seizures during VPA monotherapy. EEG was recorded for 24 h before start of VPA treatment and repeatedly during treatment. Correlation between plasma VPA concentration and reduction of the number of epileptic discharges was significant. Plasma concentration of 440-660 microM VPA was needed to achieve at least 50% reduction of seizure activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137019     DOI: 10.1111/j.1528-1157.1988.tb03759.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

Review 1.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

2.  Valproate in children with newly diagnosed idiopathic generalized epilepsy.

Authors:  K D Holland; S Monahan; D Morita; G Vartzelis; T A Glauser
Journal:  Acta Neurol Scand       Date:  2010-01-06       Impact factor: 3.209

Review 3.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.

Authors:  D Battino; M Estienne; G Avanzini
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

5.  Current Concepts in the Management of Idiopathic Generalized Epilepsies.

Authors:  Chaturbhuj Rathore; Kajal Y Patel; Parthasarthy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2022-02-01       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.